Bernard Sagaert, eTheRNA CEO

Mod­er­na co-founder, ex-Bay­er CEO jump aboard Bel­gian RNA biotech, in­vest­ing in Se­ries B round

As mR­NA has tak­en a more promi­nent perch thanks to the Covid-19 pan­dem­ic, a Eu­ro­pean biotech has now land­ed two peo­ple to its board of di­rec­tors to bring its ef­forts up to speed.

ETh­eR­NA an­nounced Tues­day that it raised $39 mil­lion in a Se­ries B2 round, se­cur­ing two big-name in­vestors: Mod­er­na co-founder Ken­neth Chien and ex-Bay­er and Ther­mo Fish­er CEO Mar­i­jn Dekkers. Both of them are join­ing the biotech’s board of di­rec­tors, ac­cord­ing to a state­ment.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.